As expected and shown by others [22], in accordance with the observed decrease in pro-inflammatory LM (Fig. 2d), STEMI and CAD patients had lower plasma levels of the n-6 PUFA AA-derived PG family (i.e., PGD2, PGE2 and PGF2α) and thromboxane (Tx)B2 compared with healthy volunteers (Fig. 5b). The gene discussed is CASP4; the disease is coronary artery disorder.